A Cure in Sight (ACIS) supports families who have ocular melanoma and focuses on research for a cure. Through public and private partnerships, we provide clear and reliable education information and access to a support community for patients and their caregivers.

ACIS educates the public about ocular melanoma, treatment options, and clinical trials that may improve a patient’s prognosis, making it less overwhelming.

ACIS is dedicated to ongoing research. We know we can accelerate viable research projects that otherwise would stall and not be completed, missing opportunities to advance research for effective treatments and possibly a cure.

A Cure in Sight bringing clarity, support and compassion to the darkness of ocular melanoma.

Last year in the United States, there were reported:
276,480 new breast cancer diagnoses*
228,000 new lung cancer diagnoses*
191,930 new prostate cancer diagnoses*
and 3,400 new eye cancer diagnoses*

The American Cancer Society(*) defines a rare or orphan cancer as any cancer, or rare disease, having fewer than 6 diagnoses per 100,000 population annually.